Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C, Genotype 1”

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Testing effectiveness (Phase 2)Study completedNCT00097045
What this trial is testing

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

Who this might be right for
Hepatitis C
Intarcia Therapeutics 90
Large-scale testing (Phase 3)Ended earlyNCT00423800
What this trial is testing

Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 56
Large-scale testing (Phase 3)Study completedNCT01366638
What this trial is testing

TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 79
Large-scale testing (Phase 3)Study completedNCT01753570
What this trial is testing

Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)

Who this might be right for
Chronic Hepatitis C(CHC)
Tanabe Pharma Corporation 74
Early research (Phase 1)Study completedNCT00230854
What this trial is testing

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis CHepatitis, Viral, Human
OPKO Health, Inc. 28
Not applicableStudy completedNCT00854802
What this trial is testing

Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 290
Large-scale testing (Phase 3)UnknownNCT00485342
What this trial is testing

RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

Who this might be right for
Chronic Hepatitis C
Hospices Civils de Lyon 236
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT01391117
What this trial is testing

TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin

Who this might be right for
Hepatitis C Virus
Tibotec BVBA 14
Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Testing effectiveness (Phase 2)Study completedNCT01482390
What this trial is testing

Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Hoffmann-La Roche 80
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Large-scale testing (Phase 3)Study completedNCT01290679
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants

Who this might be right for
Hepatitis C
Janssen R&D Ireland 393
Large-scale testing (Phase 3)Ended earlyNCT01467479
What this trial is testing

Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 185
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT02597166
What this trial is testing

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, ChronicCirrhosis, Decompensated
University Health Network, Toronto 14
Post-approval studies (Phase 4)Study completedNCT01756079
What this trial is testing

Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 58
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation